An online treatment brand may arrange the consultation while another organization dispenses the medicine. Before ordering, identify that dispensing organization. A familiar storefront logo does not tell you which pharmacy will fill your prescription or whether its license covers the relevant states.
FDA's BeSafeRx guidance recommends using a licensed pharmacy that requires an appropriate prescription, provides a US address and has a pharmacist available for questions. These are practical checks on the actual pharmacy, not a certification that an entire telehealth platform provides superior care.
Request the legal name and location
Ask for the pharmacy's name, physical address and contact details. If the assignment is made after clinical review, ask when you will receive that information. “A partner pharmacy” is a category, not enough information to perform a license lookup.
Use the relevant state board of pharmacy's official directory, reached through an official government or board website. FDA's pharmacy guidance points readers toward state licensing resources. Match the legal name and address, then check the license status and applicable state requirements. Do not rely only on a license badge displayed by the seller.
Verify contact information independently
A convincing label can still contain misleading information. FDA has reported fraudulent labels on unapproved GLP-1 products, including pharmacy identities used without authorization. If a detail is inconsistent, contact the legitimate pharmacy using a number independently obtained from its official listing or website.
Ask whether the pharmacy dispensed the actual prescription. Do not publish your prescription label or personal information in a public comment asking strangers to verify it. Use the appropriate secure channel and provide only what the pharmacist needs to identify the order.
Keep licensing and product approval separate
A licensed pharmacy can dispense compounded medication, but the pharmacy's license does not make the compounded product FDA-approved. FDA's concerns page explains why product identity and compounding circumstances need their own clinical discussion. A license check answers one question within a larger review.
Our profiles of Mochi Health and Henry Meds describe public offers involving compounded options. They do not verify a pharmacy assigned to an individual patient or certify a specific batch.
Stop the guessing when details conflict
If the label, order confirmation and pharmacy account disagree, ask the prescriber and dispensing pharmacist to reconcile them before using the product. Preserve the packaging and the relevant messages so the professionals can investigate. Do not solve an identity problem by comparing pictures with another patient's supply.
Use the delivery-problem guide for the next step when a package raises concerns. A traceable pharmacy contact makes that conversation possible; it does not replace the professional's assessment of the actual medicine.
Sources and limits
Checked October 5, 2026. Federal sources provide general guidance; provider pages describe advertised terms. These sources do not assess an individual patient's situation.
- BeSafeRx: Frequently Asked Questions (FAQs)Primary health resource; checked October 5, 2026
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight LossPrimary health resource; checked October 5, 2026